{"name":"Vincentage Pharma Co., Ltd","slug":"vincentage-pharma-co-ltd","ticker":"","exchange":"","domain":"vincentagepharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VCT220 Tablet","genericName":"VCT220 Tablet","slug":"vct220-tablet","indication":"Hypercholesterolemia","status":"phase_3"}]}],"pipeline":[{"name":"VCT220 Tablet","genericName":"VCT220 Tablet","slug":"vct220-tablet","phase":"phase_3","mechanism":"VCT220 Tablet is a small molecule that targets the PCSK9 protein to lower LDL cholesterol.","indications":["Hypercholesterolemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRWk1NDFwd3FYY1k1OHV5Wlh5V05EVThmRHd0cEdVQzZwYTNKRTNkWDBDeTRUTERqQkpwM3k0S1YxVEdRbzBYbGlzaWlPcXA1Z2NvMFdmV0Vya1Bkbmhkc1FFOEF3dWl2UGVJZmFhLThjNWpncG9XQ216cGNPMjBXVEJ2RlFOOS1rZjRWMmJlbm5hOUk1WUYxR0xOVVE?oc=5","date":"2026-01-23","type":"pipeline","source":"BioWorld News","summary":"Corxel raises $287M series D round to advance oral GLP-1 - BioWorld News","headline":"Corxel raises $287M series D round to advance oral GLP-1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQQm12WkxFamhfM25PM1M3c0hvNnpuQnF4NkNOcHpnVjFpSHprNUhyVlBzTjlSaEw2Tk1XOGFpdkxQTS1rTk1GLXVMVEpDdUU5b3RfTUpraXY2MVJVMDVxZXRFNk00S0ZpQ2gzNGFuQWttbDVwQVZSamVhY3ltZGxqUC0zX1ZPZWNSbXo1VzFuOVMxSmdU?oc=5","date":"2026-01-22","type":"pipeline","source":"BioPharma Dive","summary":"Investors load Corxel with $287M for a ‘differentiated’ obesity pill - BioPharma Dive","headline":"Investors load Corxel with $287M for a ‘differentiated’ obesity pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNOTNGakpMR0xhb3VUY0Z3RGNnRVFqaXBWRWZxUXZSMjV1WU1yRGEybW54U2ZtSnJsYW1RODFVWWh1Z3N1X0pGNEplWkVvS05GX2lzUC02Z3ZjM1NINWc4bXUwaUNxZzFMVjExZEctTzIzSE5vQnltd3ZMbXhJYzQ3NlctSmVSYTFCVU1OOFJtejVGcTJjZ1lfSzN0MDZ6UXF1RElKTjVR?oc=5","date":"2026-01-22","type":"trial","source":"Fierce Biotech","summary":"Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug - Fierce Biotech","headline":"Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQRDIyRHV0Z1BxTWp6ZHhjX3ZCMnd3RHZNdEVsMEZzdTJmVXJUNVEyalh0VEc5WG52SHd0dmM2YzE0QW03V2dWbnN6Wl9naXh4SWJfQXdMNmROc1VObGl0Vkxuc2Z0c2dEWUJPbVNucTZkSzNRaFFleWhlVW1LNHo4Z3ZocUJ6eG5iUkFPdEV6Q2ZfLW1ydjFHMGtnMUowT1h2bUpqblRvclZodWRpdVl6blpSakRkX3l5ZjQ1bUZIcjBDWVhYTENpQld4cm5PSmZaVDR5Z25DVnBtTFJmdV9jN2VkbDlLOGdBWHc?oc=5","date":"2025-06-23","type":"trial","source":"globenewswire.com","summary":"Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025 - globenewswire.com","headline":"Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQX0I2UTBnajBZZXZGdDBlRUU2N1dzMDZfZENhWGRyVGozQkNKVWZrZWFYSGNBVHo4emxtTGdlRk5TN0swaWVvelZ4ak92ejlvZ0NJdVZkSERFUFQ0UWdLYkFkZDQ0WGNNZVl0cXFKSHc2NVlhRlpsOElYZDlPSXV6dXktcWNLU3hucEZyREhmaFJuaDRKZUxsemV4YXRUMndqQzdEakY2RmQ4WF85Y2tteTJUZmRmUTZnUXZuVmdiWVQtcUh6YUt2ZTVRZk9wOHdDUmZJbXJQWUVfSnhzTGFWNW1pWVVTRWM?oc=5","date":"2025-05-06","type":"pipeline","source":"Citeline News & Insights","summary":"Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles - Citeline News & Insights","headline":"Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9aV1Qyd0R1TTh3Q2g4NEhvNXFFd3AweVByWURSWWdEN0U5QkZOLTFhLXczUjNNbUkxeDV2Y2VxcHY4YWhLalVpaC01ZThRcHNrdVhmMHBUZTJNQTN6SC1HV3VBeGpwUnJXTnE0MWx6SQ?oc=5","date":"2025-04-15","type":"regulatory","source":"Clinical Trials Arena","summary":"Corxel to begin trial of CX11 for obesity with FDA clearance - Clinical Trials Arena","headline":"Corxel to begin trial of CX11 for obesity with FDA clearance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNdzlsdnhEUWF3N2lva1h5T3NaejV0YUR5dXJzb2hZWGFGSFhLNElEUHA4ZkZXZzMzd2FXTDhGX3YwcE4yaEY2NzZzcEl2WjMxZlBGUVJubUdRRFhCX09oWHlGUUw1RU9NYXNZVzlCY196STd2N0xXcEFxNmVLTTF3Zk4wLUxkZw?oc=5","date":"2025-04-14","type":"regulatory","source":"finance.yahoo.com","summary":"CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions - finance.yahoo.com","headline":"CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Ov","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVi1fdXZ2emk0VnF3eHJNaG8wYkVDNjNqM1BRZTNxXzhQbTd3YWFVSnZfZ0trZGJrRXlrSG1sb0FtZHFDNnM0MFRsWE1CLXVOWjd0U0hfaW5JaVZjdGllalA0QnJiVklBUFlkLXZnOVJvbkRYUmw2WkVNbzBGX2c5YmxqN050SVlYRl9RVjg1N3duTmlSTTUtR3pPc2NxQncwRHdNUUZBekJscGM?oc=5","date":"2024-12-29","type":"pipeline","source":"London Stock Exchange","summary":"CORXEL Announces Two Significant Transactions - 07:00:03 29 Dec 2024 - RTW News article - London Stock Exchange","headline":"CORXEL Announces Two Significant Transactions - 07:00:03 29 Dec 2024 - RTW News article","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNUGRtc0FodHE0ZEhXVm1ZME5LSU84cG5lemkxNkFERThkVXI0N0NxTXJvSE0xT2RYd0NYQlZ6Z2ZrTUc2MmtaQ0YwS3dfTFViUE4ta1hxM1FrdjVPTDNfRkg5N1ZFN252UkZraUYxRGgwaS1hX2lZZjlWSWtidjhHcjdGTDZMNTl0XzBjSGh5aEJBWGlwRloza1dWbw?oc=5","date":"2024-12-26","type":"pipeline","source":"MedCity News","summary":"The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender - MedCity News","headline":"The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNdjlaVHp4ZVlFM0dTdEpuMWRtS25Qenh1Rm03Qzh4REg3WTUzUWZBMWFfb0xnTjlhbnNjQzlZYzBHazFnSUhyTXczTmRURGppa2JOUnk1MmtWeXJ1SVEtYUxFYjNCWE9LRzJVT083Q09kTzFUZ3RHd1VvVWFlUzRyTWhGaHd3WjVmVnd4M25ZTENSSTgxeHNlLXN2TlBmQQ?oc=5","date":"2022-06-28","type":"patent","source":"BioWorld News","summary":"Suzhou Vincentage Pharma patents GLP-1 receptor agonists - BioWorld News","headline":"Suzhou Vincentage Pharma patents GLP-1 receptor agonists","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}